Superparamagnetic iron oxide nanoparticles: promises for diagnosis and treatment of cancer.
暂无分享,去创建一个
[1] S. Thakur,et al. Emerging Implications of Nanotechnology on Cancer Diagnostics and Therapeutics , 2012 .
[2] Brian D. MacCraith,et al. Nanoparticle-based drug delivery: case studies for cancer and cardiovascular applications , 2011, Cellular and Molecular Life Sciences.
[3] B. Rashidian,et al. Raman active jagged-shaped gold-coated magnetic particles as a novel multimodal nanoprobe. , 2011, Chemical communications.
[4] Qiao Jin,et al. Biocompatible drug delivery system for photo-triggered controlled release of 5-Fluorouracil. , 2011, Biomacromolecules.
[5] Ick Chan Kwon,et al. In vivo targeted delivery of nanoparticles for theranosis. , 2011, Accounts of chemical research.
[6] Taeghwan Hyeon,et al. Multifunctional mesoporous silica nanocomposite nanoparticles for theranostic applications. , 2011, Accounts of chemical research.
[7] M. Pishko,et al. Nanoparticle-based biocompatible and targeted drug delivery: characterization and in vitro studies. , 2011, Biomacromolecules.
[8] Morteza Mahmoudi,et al. Magnetic fluid hyperthermia: focus on superparamagnetic iron oxide nanoparticles. , 2011, Advances in colloid and interface science.
[9] Morteza Mahmoudi,et al. Engineered nanoparticles for biomolecular imaging. , 2011, Nanoscale.
[10] M. Siddique,et al. Hydrothermal synthesis of alpha Fe2O3 nanoparticles capped by Tween-80 , 2011 .
[11] M. A. Holgado,et al. Possibilities of poly(D,L-lactide-co-glycolide) in the formulation of nanomedicines against cancer. , 2011, Current drug targets.
[12] Xiaoling Zhang,et al. Near-infrared light-responsive core-shell nanogels for targeted drug delivery. , 2011, ACS nano.
[13] Omid C Farokhzad,et al. Self-assembled targeted nanoparticles: evolution of technologies and bench to bedside translation. , 2011, Accounts of chemical research.
[14] M. Mahmoudi,et al. Protein-nanoparticle interactions: opportunities and challenges. , 2011, Chemical reviews.
[15] A. Milani,et al. Superparamagnetic Iron Oxide Nanoparticles: Synthesis, Surface Engineering, Cytotoxicity and Biomedical Applications , 2011 .
[16] M. Sahraian,et al. Superparamagnetic iron oxide nanoparticles: promises for diagnosis and treatment of multiple sclerosis. , 2011, ACS chemical neuroscience.
[17] Morteza Mahmoudi,et al. Effect of nanoparticles on the cell life cycle. , 2011, Chemical reviews.
[18] M. Mahmoudi,et al. Superparamagnetic colloidal nanocrystal clusters coated with polyethylene glycol fumarate: a possible novel theranostic agent. , 2011, Nanoscale.
[19] Morteza Mahmoudi,et al. Irreversible changes in protein conformation due to interaction with superparamagnetic iron oxide nanoparticles. , 2011, Nanoscale.
[20] U. Sharma,et al. Composite polymeric magnetic nanoparticles for co-delivery of hydrophobic and hydrophilic anticancer drugs and MRI imaging for cancer therapy. , 2011, ACS applied materials & interfaces.
[21] Paula T Hammond,et al. Virtual issue on nanomaterials for drug delivery. , 2011, ACS nano.
[22] Karthikeyan Subramani,et al. Magnetic resonance imaging tracking of stem cells in vivo using iron oxide nanoparticles as a tool for the advancement of clinical regenerative medicine. , 2011, Chemical reviews.
[23] Jason Park,et al. Modulation of CD4+ T lymphocyte lineage outcomes with targeted, nanoparticle-mediated cytokine delivery. , 2011, Molecular pharmaceutics.
[24] Byung-Heon Lee,et al. A novel peptide probe for imaging and targeted delivery of liposomal doxorubicin to lung tumor. , 2011, Molecular pharmaceutics.
[25] M. Mahmoudi,et al. Superparamagnetic iron oxide nanoparticles (SPIONs): development, surface modification and applications in chemotherapy. , 2011, Advanced drug delivery reviews.
[26] Duxin Sun,et al. Superparamagnetic iron oxide nanotheranostics for targeted cancer cell imaging and pH-dependent intracellular drug release. , 2010, Molecular pharmaceutics.
[27] Dmitri Artemov,et al. Nanoplex delivery of siRNA and prodrug enzyme for multimodality image-guided molecular pathway targeted cancer therapy. , 2010, ACS nano.
[28] Peter Wust,et al. Magnetic nanoparticle hyperthermia for prostate cancer , 2010, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.
[29] Omid C Farokhzad,et al. pH-Responsive nanoparticles for drug delivery. , 2010, Molecular pharmaceutics.
[30] Nishanth Krishnamurthy,et al. Optical imaging and magnetic field targeting of magnetic nanoparticles in tumors. , 2010, ACS nano.
[31] P. Wust,et al. Efficacy and safety of intratumoral thermotherapy using magnetic iron-oxide nanoparticles combined with external beam radiotherapy on patients with recurrent glioblastoma multiforme , 2010, Journal of Neuro-Oncology.
[32] Yufang Zhu,et al. Folate-Conjugated Fe3O4@SiO2 Hollow Mesoporous Spheres for Targeted Anticancer Drug Delivery , 2010 .
[33] V. Grégoire,et al. Iron oxide particles covered with hexapeptides targeted at phosphatidylserine as MR biomarkers of tumor cell death. , 2010, Contrast media & molecular imaging.
[34] Carlos Rinaldi,et al. Preparation of epidermal growth factor (EGF) conjugated iron oxide nanoparticles and their internalization into colon cancer cells , 2010 .
[35] S. Caruthers,et al. Molecular imaging of angiogenic therapy in peripheral vascular disease with ανβ3‐integrin‐targeted nanoparticles , 2010, Magnetic resonance in medicine.
[36] M. O’Donnell,et al. Multifunctional nanoparticles as coupled contrast agents. , 2010, Nature communications.
[37] Y. Shieh,et al. Magnetic chitosan/iron (II, III) oxide nanoparticles prepared by spray-drying , 2010 .
[38] T. Jovin,et al. Targeted cellular delivery of quantum dots loaded on and in biotinylated liposomes. , 2010, Bioconjugate chemistry.
[39] M. Mahmoudi,et al. Recent advances in surface engineering of superparamagnetic iron oxide nanoparticles for biomedical applications , 2010 .
[40] K. Landfester,et al. The effect of carboxydextran-coated superparamagnetic iron oxide nanoparticles on c-Jun N-terminal kinase-mediated apoptosis in human macrophages. , 2010, Biomaterials.
[41] Toshinobu Yogo,et al. High-frequency, magnetic-field-responsive drug release from magnetic nanoparticle/organic hybrid based on hyperthermic effect. , 2010, ACS applied materials & interfaces.
[42] Angela M Belcher,et al. Targeted cytosolic delivery of cell-impermeable compounds by nanoparticle-mediated, light-triggered endosome disruption. , 2010, Nano letters.
[43] A. Maharramov,et al. A SYNTHETIC MACROMOLECULE AS MRI DETECTABLE DRUG CARRIERS: AMINODEXTRAN-COATED IRON OXIDE NANOPARTICLES , 2010 .
[44] Chandana Mohanty,et al. Dual drug loaded superparamagnetic iron oxide nanoparticles for targeted cancer therapy. , 2010, Biomaterials.
[45] Sandeep Arora,et al. Breast cancers: MR imaging of folate-receptor expression with the folate-specific nanoparticle P1133. , 2010, Radiology.
[46] Hao‐Li Zhang,et al. Improving the anti-tumor effect of genistein with a biocompatible superparamagnetic drug delivery system. , 2010, Journal of nanoscience and nanotechnology.
[47] M. Nakajo,et al. Comparison of ferucarbotran‐enhanced fluid‐attenuated inversion‐recovery echo‐planar, T2‐weighted turbo spin‐echo, T2*‐weighted gradient‐echo, and diffusion‐weighted echo‐planar imaging for detection of malignant liver lesions , 2010, Journal of magnetic resonance imaging : JMRI.
[48] V. Bulmus,et al. The design and utility of polymer-stabilized iron-oxide nanoparticles for nanomedicine applications , 2010 .
[49] Igor Pantic. MAGNETIC NANOPARTICLES IN CANCER DIAGNOSIS AND TREATMENT: NOVEL APPROACHES , 2010 .
[50] J. Lewis,et al. Synthesis of bombesin-functionalized iron oxide nanoparticles and their specific uptake in prostate cancer cells , 2010, Journal of nanoparticle research : an interdisciplinary forum for nanoscale science and technology.
[51] M. Katsnelson,et al. Ligand-controlled magnetic interactions in Mn(4) clusters. , 2009, Inorganic chemistry.
[52] S. Laurent,et al. Iron oxide based MR contrast agents: from chemistry to cell labeling. , 2009, Current medicinal chemistry.
[53] Youichi Araki,et al. Perfusion study of liver lesions with superparamagnetic iron oxide: distinguishing hepatocellular carcinoma from focal nodular hyperplasia. , 2009, Clinical imaging.
[54] G. Belli,et al. Resovist enhanced MR imaging of the liver: Does quantitative assessment help in focal lesion classification and characterization? , 2009, Journal of magnetic resonance imaging : JMRI.
[55] J. Greneche,et al. Water soluble dendronized iron oxide nanoparticles. , 2009, Dalton transactions.
[56] S. Mohapatra,et al. Synthesis and stability of functionalized iron oxide nanoparticles using organophosphorus coupling agents , 2009 .
[57] Maria Triantafyllou,et al. Combined ultrasmall superparamagnetic particles of iron oxide-enhanced and diffusion-weighted magnetic resonance imaging reliably detect pelvic lymph node metastases in normal-sized nodes of bladder and prostate cancer patients. , 2009, European urology.
[58] A. Elaissari,et al. Aminodextran containing magnetite nanoparticles for molecular biology applications: preparation and evaluation. , 2009, Journal of biomedical nanotechnology.
[59] Asako Narita,et al. Facile control of silica shell layer thickness on hydrophilic iron oxide nanoparticles via reverse micelle method , 2009 .
[60] Andrew D. Miller,et al. Folate receptor targeted bimodal liposomes for tumor magnetic resonance imaging. , 2009, Bioconjugate chemistry.
[61] Abbas S. Milani,et al. Multiphysics Flow Modeling and in Vitro Toxicity of Iron Oxide Nanoparticles Coated with Poly(vinyl alcohol) , 2009 .
[62] Gary Friedman,et al. Magnetic targeting for site-specific drug delivery: applications and clinical potential. , 2009, Expert opinion on drug delivery.
[63] R. Hong,et al. Synthesis, characterization and MRI application of dextran-coated Fe3O4 magnetic nanoparticles , 2008 .
[64] Prateek Singh,et al. Folate and folate-PEG-PAMAM dendrimers: synthesis, characterization, and targeted anticancer drug delivery potential in tumor bearing mice. , 2008, Bioconjugate chemistry.
[65] Kenneth A. Dawson,et al. Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts , 2008, Proceedings of the National Academy of Sciences.
[66] Morteza Mahmoudi,et al. Optimal design and characterization of superparamagnetic iron oxide nanoparticles coated with polyvinyl alcohol for targeted delivery and imaging. , 2008, The journal of physical chemistry. B.
[67] Bing Xu,et al. Multifunctional yolk-shell nanoparticles: a potential MRI contrast and anticancer agent. , 2008, Journal of the American Chemical Society.
[68] B. Aggarwal,et al. Cancer is a Preventable Disease that Requires Major Lifestyle Changes , 2008, Pharmaceutical Research.
[69] Wah Chiu,et al. Remotely triggered liposome release by near-infrared light absorption via hollow gold nanoshells. , 2008, Journal of the American Chemical Society.
[70] C. Robic,et al. Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications. , 2008, Chemical reviews.
[71] H. A. Therese,et al. Fabrication of a Silica Coating on Magnetic γ-Fe2O3 Nanoparticles by an Immobilized Enzyme , 2008 .
[72] T. Schmitz-Rode,et al. Synthesis, physicochemical characterization and MR relaxometry of aqueous ferrofluids. , 2008, Journal of nanoscience and nanotechnology.
[73] Yu Zhang,et al. Preparation and characterization of water-soluble monodisperse magnetic iron oxide nanoparticles via surface double-exchange with DMSA , 2008 .
[74] T. Brown,et al. Magnetic resonance imaging of major histocompatibility class II expression in the renal medulla using immunotargeted superparamagnetic iron oxide nanoparticles. , 2008, ACS nano.
[75] Donghoon Lee,et al. In vivo MRI detection of gliomas by chlorotoxin-conjugated superparamagnetic nanoprobes. , 2008, Small.
[76] I. Sauer,et al. Tracking of Primary Human Hepatocytes with Clinical MRI: Initial Results with Tat-Peptide Modified Superparamagnetic Iron Oxide Particles , 2008, The International journal of artificial organs.
[77] K. Jun,et al. Nonaqueous synthesis and characterization of capped α-Fe2O3 nanoparticles from iron(III) hydroxy-oleate precursor , 2008 .
[78] B. Hamm,et al. Linking proteins with anionic nanoparticles via protamine: ultrasmall protein-coupled probes for magnetic resonance imaging of apoptosis. , 2008, Small.
[79] A. Jordan,et al. Clinical applications of magnetic nanoparticles for hyperthermia , 2008, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.
[80] Dean-Mo Liu,et al. Magnetic-sensitive silica nanospheres for controlled drug release. , 2008, Langmuir : the ACS journal of surfaces and colloids.
[81] Peter Wust,et al. Thermotherapy of prostate cancer using magnetic nanoparticles: feasibility, imaging, and three-dimensional temperature distribution. , 2007, European urology.
[82] A. Jordan,et al. Magnetic nanoparticles for intracranial thermotherapy. , 2007, Journal of nanoscience and nanotechnology.
[83] B. Rau,et al. Thermotherapie mit magnetischen Nanopartikeln , 2007, Der Onkologe.
[84] Sang Bok Lee,et al. Inorganic hollow nanoparticles and nanotubes in nanomedicine Part 1. Drug/gene delivery applications. , 2007, Drug discovery today.
[85] G. Cagney,et al. Detailed identification of plasma proteins adsorbed on copolymer nanoparticles. , 2007, Angewandte Chemie.
[86] S. Loening,et al. [Thermal therapy of prostate cancer using magnetic nanoparticles]. , 2007, Actas urologicas espanolas.
[87] Robert Ivkov,et al. Synthesis and antibody conjugation of magnetic nanoparticles with improved specific power absorption rates for alternating magnetic field cancer therapy , 2007 .
[88] S. Dutz,et al. Magnetic particle hyperthermia—biophysical limitations of a visionary tumour therapy , 2007 .
[89] E. E. Carpenter,et al. Enhanced ferrite nanoparticles as MRI contrast agents , 2007 .
[90] E. Lukevics,,et al. Synthesis and characterization of nanoparticles with an iron oxide magnetic core and a biologically active trialkylsilylated aliphatic alkanolamine shell , 2007 .
[91] Sara Linse,et al. Understanding the nanoparticle–protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles , 2007, Proceedings of the National Academy of Sciences.
[92] A. Lu,et al. Magnetic nanoparticles: synthesis, protection, functionalization, and application. , 2007, Angewandte Chemie.
[93] P Wust,et al. Morbidity and quality of life during thermotherapy using magnetic nanoparticles in locally recurrent prostate cancer: Results of a prospective phase I trial , 2007, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.
[94] P. Wust,et al. Thermotherapy using magnetic nanoparticles , 2007 .
[95] Philippe Robert,et al. Recent advances in iron oxide nanocrystal technology for medical imaging. , 2006, Advanced drug delivery reviews.
[96] D. Creanga,et al. Citric-acid-coated magnetite nanoparticles for biological applications , 2006, The European physical journal. E, Soft matter.
[97] K. Neoh,et al. Synthesis and in vitro anti-cancer evaluation of tamoxifen-loaded magnetite/PLLA composite nanoparticles. , 2006, Biomaterials.
[98] Hua Ai,et al. Multifunctional polymeric micelles as cancer-targeted, MRI-ultrasensitive drug delivery systems. , 2006, Nano letters.
[99] R. Weissleder,et al. Multivalent effects of RGD peptides obtained by nanoparticle display. , 2006, Journal of medicinal chemistry.
[100] Miqin Zhang,et al. Folic acid-PEG conjugated superparamagnetic nanoparticles for targeted cellular uptake and detection by MRI. , 2006, Journal of biomedical materials research. Part A.
[101] Jeremiah A. Johnson,et al. Toward the Syntheses of Universal Ligands for Metal Oxide Surfaces: Controlling Surface Functionality through Click Chemistry , 2006 .
[102] You Qiang,et al. Iron/iron oxide core-shell nanoclusters for biomedical applications , 2006 .
[103] Hirokazu Miyoshi,et al. Encapsulated ultrasound microbubbles: therapeutic application in drug/gene delivery. , 2006, Journal of controlled release : official journal of the Controlled Release Society.
[104] T. Ihalainen,et al. Magnetic resonance imaging of viral particle biodistribution in vivo , 2006, Gene Therapy.
[105] H. Bruhn,et al. Local Arterial Infusion of Superparamagnetic Iron Oxide Particles in Hepatocellular Carcinoma: A Feasibility and 3.0 T MRI Study , 2006, Investigative radiology.
[106] R. Weissleder,et al. Imaging pancreatic cancer with a peptide-nanoparticle conjugate targeted to normal pancreas. , 2006, Bioconjugate chemistry.
[107] Ralph Weissleder,et al. “Clickable” Nanoparticles for Targeted Imaging , 2006, Molecular imaging.
[108] Paula M Jacobs,et al. Preclinical Safety and Pharmacokinetic Profile of Ferumoxtran-10, an Ultrasmall Superparamagnetic Iron Oxide Magnetic Resonance Contrast Agent , 2006, Investigative radiology.
[109] R. Langer,et al. Investigation of targeting mechanism of new dextran-peptide-methotrexate conjugates using biodistribution study in matrix-metalloproteinase-overexpressing tumor xenograft model. , 2006, Journal of pharmaceutical sciences.
[110] Carola Leuschner,et al. Sub-cellular accumulation of magnetic nanoparticles in breast tumors and metastases. , 2006, Biomaterials.
[111] S. A. Gómez-Lopera,et al. Colloidal stability of magnetite/poly(lactic acid) core/shell nanoparticles. , 2006, Langmuir : the ACS journal of surfaces and colloids.
[112] C. Allen,et al. Epidermal growth factor-conjugated poly(ethylene glycol)-block- poly(delta-valerolactone) copolymer micelles for targeted delivery of chemotherapeutics. , 2006, Bioconjugate chemistry.
[113] S. Gubin,et al. Magnetic Nanoparticles Preparation, Structure and Properties , 2006 .
[114] Jens Ricke,et al. Magnetic nanoparticles for interstitial thermotherapy – feasibility, tolerance and achieved temperatures , 2006, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.
[115] S. Loening,et al. Thermotherapy using magnetic nanoparticles combined with external radiation in an orthotopic rat model of prostate cancer , 2006, The Prostate.
[116] Peter Wust,et al. Intracranial Thermotherapy using Magnetic Nanoparticles Combined with External Beam Radiotherapy: Results of a Feasibility Study on Patients with Glioblastoma Multiforme , 2006, Journal of Neuro-Oncology.
[117] R. Weissleder,et al. Development of nanoparticle libraries for biosensing. , 2006, Bioconjugate chemistry.
[118] Roland Felix,et al. The effect of thermotherapy using magnetic nanoparticles on rat malignant glioma , 2006, Journal of Neuro-Oncology.
[119] S. Goodman,et al. Titanium Implant Materials with Improved Biocompatibility through Coating with Phosphonate‐Anchored Cyclic RGD Peptides , 2005, Chembiochem : a European journal of chemical biology.
[120] P Wust,et al. Clinical hyperthermia of prostate cancer using magnetic nanoparticles: Presentation of a new interstitial technique , 2005, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.
[121] Francesco M Veronese,et al. PEGylation, successful approach to drug delivery. , 2005, Drug discovery today.
[122] G. Grundmeier,et al. Spectroscopic analysis of the interface chemistry of ultra-thin plasma polymer films on iron , 2005 .
[123] Bobbi K Lewis,et al. A model of lysosomal metabolism of dextran coated superparamagnetic iron oxide (SPIO) nanoparticles: implications for cellular magnetic resonance imaging , 2005, NMR in biomedicine.
[124] Jin-Sil Choi,et al. In vivo magnetic resonance detection of cancer by using multifunctional magnetic nanocrystals. , 2005, Journal of the American Chemical Society.
[125] Qing Peng,et al. A general strategy for nanocrystal synthesis , 2005, Nature.
[126] J. Duerk,et al. Magnetite‐Loaded Polymeric Micelles as Ultrasensitive Magnetic‐Resonance Probes , 2005 .
[127] Klaus Jung,et al. Magnetic fluid hyperthermia (MFH)reduces prostate cancer growth in the orthotopic Dunning R3327 rat model , 2005, The Prostate.
[128] Z. Rosenzweig,et al. Manipulation of the magnetic properties of magnetite-silica nanocomposite materials by controlled Stober synthesis. , 2005, Langmuir : the ACS journal of surfaces and colloids.
[129] T. Nishimura,et al. Monoclonal antibody A7-superparamagnetic iron oxide as contrast agent of MR imaging of rectal carcinoma , 2005, British Journal of Cancer.
[130] S. A. Gómez-Lopera,et al. Loading of 5-Fluorouracil to Poly(ethyl-2-cyanoacrylate) Nanoparticles with a Magnetic Core , 2005 .
[131] Ajay Kumar Gupta,et al. Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. , 2005, Biomaterials.
[132] Etienne Duguet,et al. A method for synthesis and functionalization of ultrasmall superparamagnetic covalent carriers based on maghemite and dextran , 2005 .
[133] E. Kim,et al. Synthesis of SPIO-chitosan microspheres for MRI-detectable embolotherapy , 2005 .
[134] C. Serna,et al. Surface characterisation of dextran-coated iron oxide nanoparticles prepared by laser pyrolysis and coprecipitation , 2005 .
[135] R. Weissleder,et al. In vivo imaging of activated endothelium using an anti-VCAM-1 magnetooptical probe. , 2005, Bioconjugate chemistry.
[136] Mingyuan Gao,et al. One‐Pot Reaction to Synthesize Biocompatible Magnetite Nanoparticles , 2005 .
[137] G. Whitesides,et al. Self-assembled monolayers of thiolates on metals as a form of nanotechnology. , 2005, Chemical reviews.
[138] Yong Zhang,et al. Surface modification of monodisperse magnetite nanoparticles for improved intracellular uptake to breast cancer cells. , 2005, Journal of colloid and interface science.
[139] Samir Mitragotri,et al. Healing sound: the use of ultrasound in drug delivery and other therapeutic applications , 2005, Nature Reviews Drug Discovery.
[140] Ralph Weissleder,et al. Detection of Vascular Adhesion Molecule-1 Expression Using a Novel Multimodal Nanoparticle , 2005, Circulation research.
[141] Younan Xia,et al. Synthesis and characterization of monodisperse silica colloids loaded with superparamagnetic iron oxide nanoparticles , 2005 .
[142] Taeghwan Hyeon,et al. Ultra-large-scale syntheses of monodisperse nanocrystals , 2004, Nature materials.
[143] Kevin M Brindle,et al. Detection of apoptosis using the C2A domain of synaptotagmin I. , 2004, Bioconjugate chemistry.
[144] Bing Xu,et al. Dopamine as a robust anchor to immobilize functional molecules on the iron oxide shell of magnetic nanoparticles. , 2004, Journal of the American Chemical Society.
[145] U. Häfeli,et al. Preparation and radiolabeling of surface-modified magnetic nanoparticles with rhenium-188 for magnetic targeted radiotherapy , 2004 .
[146] E. Groman,et al. Synthesis of ultrasmall superparamagnetic iron oxides using reduced polysaccharides. , 2004, Bioconjugate chemistry.
[147] Ming Yang,et al. Integrated microsystems for controlled drug delivery. , 2004, Advanced drug delivery reviews.
[148] S. Mitragotri,et al. Current status and future potential of transdermal drug delivery , 2004, Nature Reviews Drug Discovery.
[149] Hao Zeng,et al. Monodisperse MFe2O4 (M = Fe, Co, Mn) nanoparticles. , 2004, Journal of the American Chemical Society.
[150] J. Gallo,et al. Distribution of Small Magnetic Particles in Brain Tumor-bearing Rats , 2004, Journal of Neuro-Oncology.
[151] S. Sahoo,et al. Nanotech approaches to drug delivery and imaging. , 2003, Drug discovery today.
[152] Robert Langer,et al. Multi-pulse drug delivery from a resorbable polymeric microchip device , 2003, Nature materials.
[153] Yu Zhang,et al. Starch-Coated Superparamagnetic Nanoparticles as MR Contrast Agents , 2003 .
[154] Robert Langer,et al. Small-scale systems for in vivo drug delivery , 2003, Nature Biotechnology.
[155] Q. Pankhurst,et al. TOPICAL REVIEW: Applications of magnetic nanoparticles in biomedicine , 2003 .
[156] Afsaneh Lavasanifar,et al. Amphiphilic block copolymers for drug delivery. , 2003, Journal of pharmaceutical sciences.
[157] M. Markman. Intraperitoneal antineoplastic drug delivery: rationale and results. , 2003, The Lancet. Oncology.
[158] Vladimir P Torchilin,et al. Peptide and protein drug delivery to and into tumors: challenges and solutions. , 2003, Drug discovery today.
[159] Dmitri Artemov,et al. MR molecular imaging of the Her‐2/neu receptor in breast cancer cells using targeted iron oxide nanoparticles , 2003, Magnetic resonance in medicine.
[160] L. Illum. Nasal drug delivery--possibilities, problems and solutions. , 2003, Journal of controlled release : official journal of the Controlled Release Society.
[161] Catherine C. Berry,et al. Functionalisation of magnetic nanoparticles for applications in biomedicine : Biomedical applications of magnetic nanoparticles , 2003 .
[162] L. Illum. Nasal drug delivery: new developments and strategies. , 2002, Drug discovery today.
[163] Erkki Ruoslahti,et al. Nanocrystal targeting in vivo , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[164] P. Couvreur,et al. Nanoparticles in cancer therapy and diagnosis. , 2002, Advanced drug delivery reviews.
[165] P. Gupta,et al. Hydrogels: from controlled release to pH-responsive drug delivery. , 2002, Drug discovery today.
[166] Yang Liu,et al. Therapeutic ultrasound: Its application in drug delivery , 2002, Medicinal research reviews.
[167] Alexander V Kabanov,et al. Nanosized cationic hydrogels for drug delivery: preparation, properties and interactions with cells. , 2002, Advanced drug delivery reviews.
[168] P. Moroz,et al. Magnetically mediated hyperthermia: current status and future directions , 2002, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.
[169] K. Yao,et al. Preparation of oxidized glucose-crosslinked N-alkylated chitosan membrane and in vitro studies of pH-sensitive drug delivery behaviour. , 2002, Biomaterials.
[170] Kinam Park,et al. Environment-sensitive hydrogels for drug delivery , 2001 .
[171] H. Klok,et al. Advanced drug delivery devices via self-assembly of amphiphilic block copolymers. , 2001, Advanced drug delivery reviews.
[172] Laigui Yu,et al. Preparation and characterization of self-assembled alkanephosphate monolayers on glass substrate coated with nano-TiO2 thin film , 2001 .
[173] H. Pizem,et al. Alkyl Phosphonate/Phosphate Coating on Magnetite Nanoparticles: A Comparison with Fatty Acids , 2001 .
[174] Ming Zhao,et al. Non-invasive detection of apoptosis using magnetic resonance imaging and a targeted contrast agent , 2001, Nature Medicine.
[175] D. Mooney,et al. Polymeric system for dual growth factor delivery , 2001, Nature Biotechnology.
[176] R Weissleder,et al. Normal T-cell response and in vivo magnetic resonance imaging of T cells loaded with HIV transactivator-peptide-derived superparamagnetic nanoparticles. , 2001, Journal of immunological methods.
[177] A. Bjørnerud,et al. A targeted contrast agent for magnetic resonance imaging of thrombus: Implications of spatial resolution , 2001, Journal of magnetic resonance imaging : JMRI.
[178] S. Goodwin,et al. Single-dose toxicity study of hepatic intra-arterial infusion of doxorubicin coupled to a novel magnetically targeted drug carrier. , 2001, Toxicological sciences : an official journal of the Society of Toxicology.
[179] T. A. Hatton,et al. Structure of Alkanoic Acid Stabilized Magnetic Fluids. A Small-Angle Neutron and Light Scattering Analysis , 2001 .
[180] T. Murakami,et al. Targeted systemic chemotherapy using magnetic liposomes with incorporated adriamycin for osteosarcoma in hamsters. , 2001, International journal of oncology.
[181] C. Alexiou,et al. Locoregional cancer treatment with magnetic drug targeting. , 2000, Cancer research.
[182] T. Murakami,et al. Targeted delivery of anticancer drugs with intravenously administered magnetic liposomes in osteosarcoma-bearing hamsters. , 2000, International journal of oncology.
[183] C. Beigelman,et al. Iron oxide-enhanced MR lymphography: initial experience. , 2000, European journal of radiology.
[184] J A Frank,et al. Neurotransplantation of magnetically labeled oligodendrocyte progenitors: magnetic resonance tracking of cell migration and myelination. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[185] K. Shakesheff,et al. Polymeric systems for controlled drug release. , 1999, Chemical reviews.
[186] Carl K. Hoh,et al. Targeting and retention of magnetic targeted carriers (MTCs) enhancing intra-arterial chemotherapy , 1999 .
[187] Christian Bergemann,et al. Physiological aspects in magnetic drug-targeting , 1999 .
[188] J. Bulte,et al. Preparation, relaxometry, and biokinetics of PEGylated magnetoliposomes as MR contrast agent , 1999 .
[189] Peter Wust,et al. Endocytosis of dextran and silan-coated magnetite nanoparticles and the effect of intracellular hyperthermia on human mammary carcinoma cells in vitro , 1999 .
[190] Loftssona,et al. Cyclodextrins in ophthalmic drug delivery. , 1999, Advanced drug delivery reviews.
[191] R Weissleder,et al. High-efficiency intracellular magnetic labeling with novel superparamagnetic-Tat peptide conjugates. , 1999, Bioconjugate chemistry.
[192] B. Chu,et al. Preparation and Properties of Magnetite and Polymer Magnetite Nanoparticles , 1999 .
[193] M. Cima,et al. A controlled-release microchip , 1999, Nature.
[194] Henry,et al. Microfabricated microneedles: A novel approach to transdermal drug delivery , 1999, Journal of pharmaceutical sciences.
[195] W. Kaiser,et al. Physical limits of hyperthermia using magnetite fine particles , 1998 .
[196] W Semmler,et al. Targeting of ultrasmall superparamagnetic iron oxide (USPIO) particles to tumor cells in Vivo by using transferrin receptor pathways , 1998, Magnetic resonance in medicine.
[197] Nathalie Siauve,et al. Liver Imaging With Ferumoxides (Feridex®): Fundamentals, Controversies, and Practical Aspects , 1998, Topics in magnetic resonance imaging : TMRI.
[198] J. Bacri,et al. Biomedical applications of maghemite ferrofluid. , 1998, Biochimie.
[199] P. Sado,et al. Ophthalmic drug delivery systems—Recent advances , 1998, Progress in Retinal and Eye Research.
[200] J. Gallo,et al. Enhanced brain tumor selectivity of cationic magnetic polysaccharide microspheres. , 1998, Journal of drug targeting.
[201] C. Marx,et al. SPIO‐enhanced 2D‐TOF MR angiography of the portal venous system: Results of an intraindividual comparison , 1997, Journal of magnetic resonance imaging : JMRI.
[202] A. Bée,et al. Thiolation of Maghemite Nanoparticles by Dimercaptosuccinic Acid , 1997, Journal of colloid and interface science.
[203] Luigi Naldini,et al. Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo , 1997, Nature Biotechnology.
[204] Sung Wan Kim,et al. Biodegradable block copolymers as injectable drug-delivery systems , 1997, Nature.
[205] N Lotan,et al. Large porous particles for pulmonary drug delivery. , 1997, Science.
[206] P Reichardt,et al. Clinical experiences with magnetic drug targeting: a phase I study with 4'-epidoxorubicin in 14 patients with advanced solid tumors. , 1996, Cancer research.
[207] D. Huhn,et al. Preclinical experiences with magnetic drug targeting: tolerance and efficacy. , 1996, Cancer research.
[208] T. Egan,et al. Intravenous drug delivery systems: toward an intravenous "vaporizer". , 1996, Journal of clinical anesthesia.
[209] F. Gage,et al. In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral Vector , 1996, Science.
[210] G Gregoriadis,et al. Engineering liposomes for drug delivery: progress and problems. , 1995, Trends in biotechnology.
[211] J M Gallo,et al. Preparation and in vitro evaluation of magnetic microsphere-methotrexate conjugate drug delivery systems. , 1995, Bioconjugate chemistry.
[212] C. W. Jung. Surface properties of superparamagnetic iron oxide MR contrast agents: ferumoxides, ferumoxtran, ferumoxsil. , 1995, Magnetic resonance imaging.
[213] R Weissleder,et al. Determinants of in vivo MR imaging of slow axonal transport. , 1994, Radiology.
[214] R. Lufkin,et al. Dextran-coated superparamagnetic iron oxide, an MR contrast agent for assessing lymph nodes in the head and neck. , 1994, AJNR. American journal of neuroradiology.
[215] J. Weaver,et al. Electroporation of mammalian skin: a mechanism to enhance transdermal drug delivery. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[216] L. Brannon-Peppas. Novel vaginal drug release applications , 1993 .
[217] S. Margel,et al. Synthesis and characterization of self-assembled hydrophobic monolayer coatings on silica colloids , 1993 .
[218] P. Bunn,et al. Synthesis and evaluation of colloidal magnetic iron oxides for the site-specific radiofrequency-induced hyperthermia of cancer , 1993 .
[219] K. Go,et al. Our approach towards developing a specific tumour-targeted MRI contrast agent for the brain. , 1993, European journal of radiology.
[220] P. Wust,et al. Inductive heating of ferrimagnetic particles and magnetic fluids: physical evaluation of their potential for hyperthermia. , 1993, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.
[221] A. Fischman,et al. Polyclonal human immunoglobulin G labeled with polymeric iron oxide: antibody MR imaging. , 1991, Radiology.
[222] R. Feeney,et al. Chemical Modifications of Proteins: History and Applications , 1990 .
[223] J M Collins,et al. Pharmacologic rationale for regional drug delivery. , 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[224] K. Widder,et al. Selective targeting of magnetic albumin microspheres containing low-dose doxorubicin: total remission in Yoshida sarcoma-bearing rats. , 1983, European journal of cancer & clinical oncology.
[225] R. Molday,et al. Immunospecific ferromagnetic iron-dextran reagents for the labeling and magnetic separation of cells. , 1982, Journal of immunological methods.
[226] K. Widder,et al. In vivo kinetics of magnetically targeted low-dose doxorubicin. , 1981, Journal of pharmaceutical sciences.
[227] K. Widder,et al. Tumor remission in Yoshida sarcoma-bearing rts by selective targeting of magnetic albumin microspheres containing doxorubicin. , 1981, Proceedings of the National Academy of Sciences of the United States of America.
[228] K. Widder,et al. Magnetically responsive microspheres and other carriers for the biophysical targeting of antitumor agents. , 1979, Advances in pharmacology and chemotherapy.